Twin reversed arterial perfusion
A rare complication of monochorionic twin pregnancies
Twin reversed arterial perfusion (TRAP) sequence is a rare complication of monochorionic twin pregnancies, where one twin, known as the "acardiac twin," is severely malformed and lacks a functioning heart. The other twin, referred to as the "pump twin," provides circulation for both twins, leading to significant health risks.
Pathophysiology[edit | edit source]
In TRAP sequence, the acardiac twin receives blood from the pump twin through abnormal arterial anastomoses in the placenta. This reversed blood flow results in the acardiac twin developing without a heart and often without a head, leading to severe malformations. The pump twin is at risk of heart failure due to the increased cardiac workload.
Diagnosis[edit | edit source]
TRAP sequence is typically diagnosed through ultrasound imaging, which reveals the presence of an acardiac twin. The acardiac twin may appear as a mass with no cardiac activity, and the pump twin may show signs of hydrops fetalis if heart failure is developing.
Management[edit | edit source]
Management of TRAP sequence focuses on monitoring the pump twin and may involve interventions to reduce the cardiac load on the pump twin. Options include radiofrequency ablation or laser coagulation of the vessels supplying the acardiac twin. In some cases, early delivery may be necessary.
Prognosis[edit | edit source]
The prognosis for the pump twin depends on the size of the acardiac twin and the degree of cardiac strain. Early detection and intervention can improve outcomes, but the condition remains high-risk.
Related pages[edit | edit source]
References[edit | edit source]
- Hecher, K., et al. (2001). "Twin reversed arterial perfusion: A systematic review of literature." Prenatal Diagnosis, 21(8), 693-699.
- Lewi, L., et al. (2010). "The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester." American Journal of Obstetrics and Gynecology, 203(3), 213.e1-213.e4.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD